DualityBio Adds 0.40 Million Shares After Series of Option Exercises

Bulletin Express09-28 21:05

Duality Biotherapeutics, Inc. (DualityBio) disclosed that 399,683 new ordinary shares were issued between 1 and 28 September 2026 through 21 separate option exercises under its Pre-IPO Equity Incentive Plan.

• Scale of dilution: The newly issued shares represent approximately 0.44 % of the company’s previously outstanding 90.83 million shares.

• Share count update: Issued shares (excluding treasury shares) increased to 91.23 million, while treasury shares remained unchanged at 0.40 million, lifting total issued capital to 91.63 million shares.

• Pricing details: Exercise prices ranged from HKD 166.73 to HKD 214.35 per share. The weighted-average exercise price was roughly HKD 195.05, generating an estimated HKD 77.98 million in gross proceeds.

• Insider activity: A director exercised 40,000 options on 28 September 2026 at HKD 196.05 per share.

• No repurchases: The filing reports no share buybacks or treasury-share sales during the period.

The board confirmed that all option exercises complied with Hong Kong Listing Rule 13.25A requirements and that all proceeds have been duly received.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment